Aliases & Classifications for Vulvar Disease

MalaCards integrated aliases for Vulvar Disease:

Name: Vulvar Disease 12 15
Vulvar Diseases 44 73
Vulvar Disorders 43

Classifications:



External Ids:

Disease Ontology 12 DOID:2059
MeSH 44 D014845
NCIt 50 C27631
SNOMED-CT 68 5089007
UMLS 73 C0042994

Summaries for Vulvar Disease

MedlinePlus : 43 The vulva is the external part of a woman's genitals. Some problems you can have with the vulvar area include Vaginitis or vulvovaginitis, swelling or infection of the vulva and vagina Skin problems due to allergy Vulvar cancer Vulvodynia, or vulvar pain Symptoms may include redness, itching, pain, or cracks in the skin. Treatment depends on the cause.

MalaCards based summary : Vulvar Disease, also known as vulvar diseases, is related to vulvar dystrophy and vulvitis, and has symptoms including pelvic pain and pruritus vulvae. An important gene associated with Vulvar Disease is CDKN2A (Cyclin Dependent Kinase Inhibitor 2A), and among its related pathways/superpathways are Oncogene Induced Senescence and Bladder cancer. The drugs Acetylcholine and Miconazole have been mentioned in the context of this disorder. Affiliated tissues include skin, lung and kidney.

Disease Ontology : 12 A female reproductive system diseaes that is located in the vulva.

Wikipedia : 76 A vulvar disease is a particular abnormal, pathological condition that affects part or all of the vulva.... more...

Related Diseases for Vulvar Disease

Diseases related to Vulvar Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 133)
# Related Disease Score Top Affiliating Genes
1 vulvar dystrophy 31.7 CDKN2A LINC01191
2 vulvitis 31.6 KRT7 LINC01191
3 vulvar intraepithelial neoplasia 29.9 KRT7 TP53
4 in situ carcinoma 29.7 CDKN2A TP53
5 ulceration of vulva 11.0
6 atrophic vulva 11.0
7 bladder squamous cell carcinoma 10.3 CDKN2A TP53
8 keratinizing squamous cell carcinoma 10.3 CDKN2A TP53
9 spitz nevus 10.3 CDKN2A TP53
10 scrotal carcinoma 10.3 CDKN2A TP53
11 bartholin's gland disease 10.3 CDKN2A TP53
12 anal squamous cell carcinoma 10.3 CDKN2A TP53
13 megaesophagus 10.2 CDKN2A TP53
14 gastric adenosquamous carcinoma 10.2 CDKN2A TP53
15 anogenital venereal wart 10.2 CDKN2A TP53
16 inverted transitional papilloma 10.2 CDKN2A KRT7
17 oral leukoplakia 10.2 CDKN2A TP53
18 meningeal melanomatosis 10.2 CDKN2A TP53
19 adenoid basal cell carcinoma 10.2 CDKN2A KRT7
20 malignant spiradenoma 10.2 KRT7 TP53
21 bile duct adenoma 10.2 CDKN2A KRT7
22 suppressor of tumorigenicity 3 10.2 CDKN2A TP53
23 spiradenoma 10.2 KRT7 TP53
24 endocervical carcinoma 10.2 CDKN2A KRT7
25 nasal cavity cancer 10.2 CDKN2A KRT7
26 dedifferentiated liposarcoma 10.2 CDKN2A TP53
27 anal canal carcinoma 10.2 CDKN2A KRT7
28 papillary serous adenocarcinoma 10.2 KRT7 TP53
29 female reproductive endometrioid cancer 10.2 KRT7 TP53
30 cervix small cell carcinoma 10.2 CDKN2A TP53
31 mucinous bronchioloalveolar adenocarcinoma 10.2 CDKN2A KRT7
32 verrucous carcinoma 10.2 CDKN2A TP53
33 well-differentiated liposarcoma 10.2 CDKN2A KRT7
34 prostate squamous cell carcinoma 10.2 KRT7 TP53
35 optic nerve neoplasm 10.2 CDKN2A TP53
36 pleomorphic carcinoma 10.2 KRT7 TP53
37 nasal cavity squamous cell carcinoma 10.2 CDKN2A KRT7
38 biliary papillomatosis 10.2 KRT7 TP53
39 eccrine sweat gland neoplasm 10.2 KRT7 TP53
40 juvenile pilocytic astrocytoma 10.2 CDKN2A TP53
41 appendix cancer 10.2 KRT7 TP53
42 cervical adenosquamous carcinoma 10.2 CDKN2A KRT7
43 epithelial-myoepithelial carcinoma 10.2 KRT7 TP53
44 pre-malignant neoplasm 10.2 CDKN2A TP53
45 cystic teratoma 10.2 KRT7 TP53
46 recessive dystrophic epidermolysis bullosa 10.2 CDKN2A TP53
47 adenocarcinoma in situ 10.2 CDKN2A KRT7
48 mixed cell type cancer 10.2 KRT7 TP53
49 squamous cell papilloma 10.2 CDKN2A TP53
50 non-invasive bladder papillary urothelial neoplasm 10.2 TP53 UPK3A

Graphical network of the top 20 diseases related to Vulvar Disease:



Diseases related to Vulvar Disease

Symptoms & Phenotypes for Vulvar Disease

UMLS symptoms related to Vulvar Disease:


pelvic pain, pruritus vulvae

Drugs & Therapeutics for Vulvar Disease

Drugs for Vulvar Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 210)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Acetylcholine Approved Phase 4,Phase 3,Phase 2 51-84-3 187
2
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 22916-47-8 4189
3
Fluconazole Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 86386-73-4 3365
4
Clotrimazole Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 23593-75-1 2812
5
Dequalinium Approved, Investigational Phase 4 6707-58-0
6
Terconazole Approved Phase 4,Phase 3,Not Applicable 67915-31-5 441383
7
Petrolatum Approved, Investigational Phase 4,Phase 2,Not Applicable 8009-03-8
8 Acetylcholine Release Inhibitors Phase 4,Phase 3,Phase 2
9 Botulinum Toxins Phase 4,Phase 3,Phase 2
10 onabotulinumtoxinA Phase 4,Phase 3,Phase 2
11 Cholinergic Agents Phase 4,Phase 3,Phase 2
12 abobotulinumtoxinA Phase 4,Phase 3,Phase 2
13 Neurotransmitter Agents Phase 4,Phase 3,Phase 2,Not Applicable
14 Botulinum Toxins, Type A Phase 4,Phase 3,Phase 2
15 Antifungal Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
16 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
17 Cytochrome P-450 Enzyme Inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
18 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
19 Steroid Synthesis Inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
20 Cytochrome P-450 CYP2C9 Inhibitors Phase 4,Phase 3,Phase 2,Phase 1
21 Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
22 Hormones Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
23 Cytochrome P-450 CYP2C19 Inhibitors Phase 4,Phase 3,Phase 2,Phase 1
24 Estrogens Phase 4,Not Applicable
25 Cytochrome P-450 CYP3A Inhibitors Phase 4,Phase 3,Not Applicable
26 Anti-Infective Agents, Local Phase 4,Phase 3
27 Tea Phase 4
28
Amitriptyline Approved Phase 3 50-48-6 2160
29
Perphenazine Approved Phase 3 58-39-9 4748
30 Tomato Approved Phase 3
31
Nifedipine Approved Phase 3 21829-25-4 4485
32
Milnacipran Approved, Investigational Phase 3 92623-85-3 65833
33
Butoconazole Approved Phase 3,Not Applicable 64872-77-1, 64872-76-0 47472
34
Clindamycin Approved, Vet_approved Phase 3,Not Applicable 18323-44-9 29029
35
Lidocaine Approved, Vet_approved Phase 3,Phase 2,Phase 1,Not Applicable 137-58-6 3676
36
Amphotericin B Approved, Investigational Phase 3,Phase 2 1397-89-3 5280965 14956
37
Tetracycline Approved, Vet_approved Phase 3 60-54-8 5353990
38
Ketoconazole Approved, Investigational Phase 3 65277-42-1 3823 47576
39
Octreotide Approved, Investigational Phase 3 83150-76-9 383414 6400441
40
Capsaicin Approved Phase 2, Phase 3,Phase 1 404-86-4 1548943
41
Clobetasol Approved, Experimental, Investigational Phase 3,Phase 2,Not Applicable 25122-46-7, 25122-41-2 5311051 32798
42
Cisplatin Approved Phase 3,Phase 2,Phase 1 15663-27-1 2767 441203 84093
43 Antidepressive Agents, Tricyclic Phase 3,Not Applicable
44 Central Nervous System Depressants Phase 3,Phase 2,Phase 1,Not Applicable
45 Analgesics, Non-Narcotic Phase 3,Phase 2,Phase 1
46 Amitriptyline, perphenazine drug combination Phase 3
47 Antidepressive Agents Phase 3,Phase 2,Not Applicable
48 Analgesics Phase 3,Phase 2,Phase 1,Not Applicable
49 Psychotropic Drugs Phase 3,Phase 2,Not Applicable
50 Antipsychotic Agents Phase 3

Interventional clinical trials:

(show top 50) (show all 234)
# Name Status NCT ID Phase Drugs
1 Botox on Vulvar Vestibulitis Unknown status NCT00119886 Phase 4 Botulinum toxin
2 Epidemiological Study About the Evolution of Patients Treated for an Acute Episode of Vulvovaginal Candidiasis Completed NCT02248506 Phase 4
3 Comparative Efficacy Study of 10 mg Dequalinium Chloride (Fluomizin) in the Treatment of Vulvovaginal Candidiasis Completed NCT02242695 Phase 4 Fluomizin vaginal tablets;Canesten vaginal tablets
4 Clotrimazole Vaginal Tablet vs Fluconazole for Severe Vulvovaginal Candidiasis Completed NCT02180828 Phase 4 Clotrimazole vaginal tablet;Fluconazole
5 Terconazole Vaginal Suppository vs Fluconazole for the Treatment of Severe Vulvovaginal Candidiasis Completed NCT02180100 Phase 4 Terconazole Vaginal Suppository;Fluconazole
6 Effect of Exercise on Spread of the Miconozole Nitrate OVULE in the Vagina Completed NCT00194324 Phase 4 Miconazole nitrate
7 Topical Treatment for Sexual Pain, Vulvar Pain, in Postmenopausal Women Not Taking Estrogens or Similiar Hormones Recruiting NCT03682601 Phase 4 Sinecatechins Topical
8 Physical Therapy as Adjuvant Treatment of Vulvodynia: a Randomized Controled Trial Unknown status NCT02871661 Phase 3 Amitriptyline
9 Dysbiosis in Localized Provoked Vulvodynia (LPV) Unknown status NCT02393911 Phase 3
10 Efficacy Study of Topical Application of Nifedipine Cream to Treat Vulvar Vestibulitis Completed NCT00496184 Phase 3 Nifedipine cream topical application
11 Savella in Treatment for Provoked Vestibulodynia Completed NCT01304589 Phase 3 Milnacipran
12 Vaginal Infection Study Completed NCT00616330 Phase 3 clindamycin phosphate/butoconazole nitrate;clindamycin phosphate;butoconazole nitrate
13 Radiation Therapy or Surgery in Treating Patients With Previously Untreated Vulva Cancer With Positive Groin Lymph Nodes Completed NCT00898352 Phase 3
14 Prospective and Randomized Study to Evaluate Interest of Ultracision Use in Inguinal Lymph Nodes Curage Completed NCT00224744 Phase 3
15 Lymphatic Mapping in Treating Patients With Stage I or Stage II Cancer of the Vulva Completed NCT00003325 Phase 3
16 Immunogenicity and Tolerability of Broad Spectrum Human Papillomavirus (HPV) Vaccine in Adult and Young Adult Women (V503-004) Completed NCT03158220 Phase 3
17 Therapy to Prevent Sexual Pain in Breast Cancer Survivors Completed NCT01539317 Phase 3 Topical liquid lidocaine;Topical saline
18 Study of the Efficacy and Tolerance of Intra-vaginal Treatment With a Total Freeze-dried Culture of Lcr Regenerans® in the Prevention of Relapses of Recurrent Vulvovaginal Candidiasis Completed NCT02251093 Phase 3 Lcr Regenerans;Placebo
19 The Study Of Fluconazole For Vulvovaginal Candidiasis Completed NCT01806623 Phase 3 Fluconazole
20 A Study to Compare the Efficacy and Safety of a Combination of Ketoconazole and Clindamycin Compared to Tetracycline/Amphotericin B Combination Cream for the Treatment of Bacterial Vaginosis and Vaginal Candidiasis (P08077) Completed NCT01293643 Phase 3 100 mg clindamycin /800 mg ketoconazole vaginal ovule;100 mg tetracycline hydrochloride /50 mg amphotericin B cream
21 A Study of V503, a 9-valent Human Papillomavirus (9vHPV) Vaccine in Females 12-26 Years of Age Who Have Previously Received GARDASIL™ (V503-006) Completed NCT01047345 Phase 3
22 Comparative Efficacy of Ovule vs Tablet Completed NCT00755053 Phase 3 Clotrimazole, vaginal ovule;Clotrimazole, vaginal tablet
23 Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001) Completed NCT00543543 Phase 3
24 Diabetes Mellitus and Vulvovaginal Candidiasis Completed NCT00353561 Phase 3 Boric;Fluconazole
25 Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis Completed NCT00033605 Phase 3 octreotide acetate
26 Fibrin Sealant in Decreasing Lymphedema Following Surgery to Remove Lymph Nodes in Patients With Cancer of the Vulva Completed NCT00028951 Phase 3 fibrin sealant
27 A Pilot Study of the Effects of Botulinum Toxin in the Treatment of Provoked Vestibulodynia Recruiting NCT02858219 Phase 3 Botulinum Toxin Type A
28 A Study of the Effects of Topical Capsaicin in the Treatment of Provoked Vestibulodynia Recruiting NCT02854670 Phase 2, Phase 3 Capsaicin patch
29 Placebo-controlled RCT of Botulinum Toxin A as a Treatment for Provoked Vestibulodynia Recruiting NCT02773641 Phase 3 Botulinum Toxin Type A;Sterile Saline Solution
30 Clobetasol Proprionate Versus Fractionated CO2 Laser for the Treatment of Lichen Sclerosus Recruiting NCT02573883 Phase 3 Clobetasol Propionate 0.05% ointment
31 Treatment of Candidal Vulvovaginitis Using Cumin Seed Extract Vaginal Cream. Recruiting NCT03005353 Phase 2, Phase 3 Cumin seed extract;clotrimazole
32 Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis Recruiting NCT03734991 Phase 3 Ibrexafungerp;Placebo
33 A Study of Oral VT-1161 for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection) Recruiting NCT03562156 Phase 3 VT-1161;Placebo
34 A Study of Oral VT-1161 for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection) Recruiting NCT03561701 Phase 3 VT-1161;Placebo
35 ProF-001_Phase IIa Recruiting NCT03115073 Phase 2, Phase 3 Candiplus;Clotrimazole
36 Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery Recruiting NCT02997553 Phase 3 Indocyanine green;Technetium99
37 Safety and Immunogenicity Study of V503 (GARDASIL™9, 9vHPV Vaccine) Administered to 9- to 26-Year-Old Females and Males in Vietnam Active, not recruiting NCT03546842 Phase 3
38 A Study of V503 (A Multivalent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] Vaccine) in Preadolescents and Adolescents (V503-002) Active, not recruiting NCT00943722 Phase 3
39 Ketoconazole Gel Versus Terconazole Cream for Vaginal Candidiasis Not yet recruiting NCT03473418 Phase 3 Ketoconazole;Terconazole
40 Efficacy, Safety LactiSal 1% Gel, LactSal 50 mg, Clotrimazole 100 mg Tablet in Treatment Vulvovaginal Candidiasis Not yet recruiting NCT02907307 Phase 3 Clotrimazole vaginal tablet 100mg
41 Radiation Therapy With or Without Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Cancer of the Vulva Terminated NCT00006096 Phase 3 cisplatin
42 Flexitouch® Home Maintenance Therapy or Standard Home Maintenance Therapy in Treating Patients With Lower-Extremity Lymphedema Caused by Treatment for Cervical Cancer, Vulvar Cancer, or Endometrial Cancer Terminated NCT00577317 Phase 3
43 Nutritional Supplements in Improving Quality of Life During First-Line Chemotherapy in Patients With Metastatic Gynecological Cancer Unknown status NCT00905658 Phase 2
44 Phase I/II Randomized, Placebo-Controlled Study of Capsaicin for Interstitial Cystitis and Vulvar Vestibulitis Completed NCT00004316 Phase 1, Phase 2 capsaicin
45 Infiltration of the Vestibulum Vaginae With Botulin Toxin in Patients With Localized Provoked Vulvodynia Completed NCT01747161 Phase 2 Botulin toxin;physiological water
46 Enoxaparin as Treatment for Vulvodynia Completed NCT00874484 Phase 2 Clexane (enoxaparin)
47 CC-10004 For The Treatment Of Vulvodynia Completed NCT00814632 Phase 2 CC-10004
48 Safety and Efficacy of Two Vaginal Products Versus Placebo in Patients With Vaginal Discomfort Completed NCT00590590 Phase 2 Lidocaine/Diphenhydramine;lidocaine;placebo
49 Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC) Completed NCT02971007 Phase 2 Oral Encochleated Amphotericin B (CAMB);Fluconazole
50 RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections Completed NCT02733432 Phase 2 CD101 Vaginal Gel (3%);CD101 External gel (1%);CD101 Vaginal Ointment (6%);CD101 External ointment (1%);Fluconazole

Search NIH Clinical Center for Vulvar Disease

Cochrane evidence based reviews: vulvar diseases

Genetic Tests for Vulvar Disease

Anatomical Context for Vulvar Disease

MalaCards organs/tissues related to Vulvar Disease:

41
Skin, Lung, Kidney, Liver, Tongue, Ovary, Cervix

The Foundational Model of Anatomy Ontology organs/tissues related to Vulvar Disease:

19
The Vulva

Publications for Vulvar Disease

Articles related to Vulvar Disease:

(show top 50) (show all 67)
# Title Authors Year
1
"The Future of Vulvar Disease: New and Ongoing Challenges": Presidential Lecture - XXIV World Congress 2017, Mendoza, Argentina. ( 29474239 )
2018
2
Lichenoid vulvar disease: A review. ( 28492056 )
2017
3
Evaluation and Management of Vulvar Disease. ( 28778648 )
2017
4
HPV-related vulvar diseases and perspectives of p16INK4a immunochemistry: a review of the literature. ( 28574130 )
2017
5
Primary extramammary invasive Paget's vulvar disease: what is the standard, what are the challenges and what is the future for radiotherapy? ( 27473174 )
2016
6
What Do Patients Want? A Needs Assessment of Vulvodynia Patients Attending a Vulvar Diseases Clinic. ( 27484917 )
2016
7
Sexual well-being in patients with vulvar disease: results from a preliminary prospective matched case-control study. ( 26342683 )
2015
8
Psychosexual Aspects of Vulvar Disease. ( 26125964 )
2015
9
Lower Urinary Tract and Functional Bowel Symptoms in Women With Vulvar Diseases and Controls. ( 26052645 )
2015
10
Paediatric vulvar disease. ( 25134451 )
2014
11
Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data. ( 22454089 )
2012
12
Considerations for disease impact and outcome measures in vulvar disease. ( 22659774 )
2012
13
Prevalences of and risk factors for vulvar diseases in Nepal: a hospital-based study. ( 21244379 )
2011
14
The impact of the latest classification system of benign vulvar diseases on the management of women with chronic vulvar pruritus. ( 21508567 )
2011
15
Human papillomavirus infections and vulvar disease development. ( 19505910 )
2009
16
Vulvar diseases of the tropics: a review. ( 19301568 )
2009
17
Bladder and bowel symptoms among women with vulvar disease: are they universal? ( 18210896 )
2007
18
Vulvar disease pearls. ( 16677963 )
2006
19
Vulvar disease update. ( 17249297 )
2006
20
Vulvar disease: a pelvic floor pain disorder? ( 15970821 )
2005
21
Vulvar disease. ( 12100817 )
2002
22
The serious clinical problem of chronic vulvar disease. ( 12230080 )
2002
23
Adverse behavioral and sexual factors in chronic vulvar disease. ( 10920305 )
2000
24
Vulvar disease in children: a clinical audit of 130 cases. ( 10720979 )
2000
25
Dyspareunia and vulvar disease. ( 9839263 )
1998
26
The commonest causes of symptomatic vulvar disease: a dermatologist's perspective. ( 8936065 )
1996
27
Treatment of human papillomavirus-associated vulvar disease with the CO2-laser. Physical and histological aspects with use of a new scanning device, the SwiftLase. ( 8933926 )
1996
28
Clinicopathologic analysis of 370 cases of vulvar intraepithelial neoplasia. Italian Study Group on Vulvar Disease. ( 8887191 )
1996
29
Vulvar disease in the pediatric population. ( 8723821 )
1996
30
Office gynecology for the primary care physician, part II: pelvic pain, vulvar disease, disorders of menstruation, premenstrual syndrome, and breast disease. ( 8614176 )
1996
31
Proceedings of the 11th International Congress of the International Society for the Study of Vulvar Disease. Oxford, England, September 1991. ( 8095071 )
1993
32
International Society for the Study of Vulvar Disease. ( 8441124 )
1993
33
Advances in vulvar disease: lichen sclerosus et atrophicus et al. ( 1739579 )
1992
34
Vulvar diseases. ( 1606758 )
1992
35
General principles in the diagnosis and treatment of vulvar diseases. ( 1606759 )
1992
36
Ultrasonic surgical aspiration in the treatment of vulvar disease. ( 2002980 )
1991
37
Ultrasonic surgical aspiration in the treatment of vulvar disease. ( 1876389 )
1991
38
New nomenclature for vulvar disease. Report of the Committee on Terminology of the International Society for the Study of Vulvar Disease. ( 2352242 )
1990
39
Proceedings of the 10th International Congress of the International Society for the Study of Vulvar Disease, Washington, D.C., October 1989. ( 1980515 )
1990
40
Proceedings of the Tenth World Congress of the International Society for the Study of Vulvar Disease, Washington, D.C., October 22-26, 1989. ( 1980928 )
1990
41
Superficial laser vulvectomy. IV. Extended laser vaporization and adjunctive 5-fluorouracil therapy of human papillomavirus-associated vulvar disease. ( 2166264 )
1990
42
Surgical-procedure terminology for the vulva and vagina. Report of an International Society for the Study of Vulvar Disease Task Force. ( 2277365 )
1990
43
The 1989 presidential address. International Society for the Study of Vulvar Disease. ( 2277371 )
1990
44
A critique of current classifications of vulvar diseases. ( 2203271 )
1990
45
New nomenclature for vulvar disease: International Society for the Study of Vulvar Disease. ( 2707802 )
1989
46
Proceedings of the ninth world congress of the International Society for the Study of Vulvar Disease. Queensland, Australia, September 1987. ( 3172073 )
1988
47
International Society for the Study of Vulvar Disease--progress report. ( 3395571 )
1988
48
Proceedings of the Eighth World Congress of the International Society for the Study of Vulvar Disease. Mariehamn, Finland, September 9-15, 1985. ( 3772896 )
1986
49
Selected ISSVD (International Society for the Study of Vulvar Disease) abstracts. ( 3783540 )
1986
50
The carbon dioxide laser in the treatment of vulvar disease. ( 3921303 )
1985

Variations for Vulvar Disease

Expression for Vulvar Disease

Search GEO for disease gene expression data for Vulvar Disease.

Pathways for Vulvar Disease

Pathways related to Vulvar Disease according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 10.76 CDKN2A TP53
2 10.66 CDKN2A TP53 UPK3A
3 10.5 CDKN2A TP53
4
Show member pathways
10.3 CDKN2A TP53

GO Terms for Vulvar Disease

Cellular components related to Vulvar Disease according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular exosome GO:0070062 9.1 GP5 KRT13 KRT7 SCN10A SERPINB3 UPK3A

Biological processes related to Vulvar Disease according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 replicative senescence GO:0090399 8.62 CDKN2A TP53

Molecular functions related to Vulvar Disease according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 disordered domain specific binding GO:0097718 8.62 CDKN2A TP53

Sources for Vulvar Disease

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....